Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Attention-deficit/Hyperactivity Disorder”

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07803224
What this trial is testing

Adult ADHD Symptoms, Depression, Anxiety, and Academic Performance in Medical Students

Who this might be right for
Attention Deficit Hyperactivity DisorderDepressionAnxiety+1 more
Assiut University 52
Testing effectiveness (Phase 2)Study completedNCT00664703
What this trial is testing

Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Yaupon Therapeutics 13
Large-scale testing (Phase 3)Study completedNCT00714688
What this trial is testing

Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder

Who this might be right for
Attention Deficit/ Hyperactivity Disorder
Janssen-Cilag International NV 279
Testing effectiveness (Phase 2)Study completedNCT02699086
What this trial is testing

PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)

Who this might be right for
Attention-Deficit Hyperactivity Disorder (ADHD)
BioLite, Inc. 6
Early research (Phase 1)Ended earlyNCT02827513
What this trial is testing

Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects

Who this might be right for
Adult Attention-deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Development & Commercialization, Inc. 16
Large-scale testing (Phase 3)Study completedNCT02555150
What this trial is testing

A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD

Who this might be right for
Attention Deficit Hyperactivity Disorder
Rhodes Pharmaceuticals, L.P. 40
Not applicableStudy completedNCT01160874
What this trial is testing

Sleepiness and Driving Performances in Adults With Attention-Deficit/ Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Disorder With Hyperactivity
University Hospital, Bordeaux 80
Not applicableLooking for participantsNCT06284655
What this trial is testing

The Effect of a Brief Educational Intervention for Adults With ADHD

Who this might be right for
ADHD
St. Olavs Hospital 60
Very early researchStudy completedNCT03676725
What this trial is testing

Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD

Who this might be right for
ADHDPMS
PhenoSolve, LLC 90
Not applicableUnknownNCT06479850
What this trial is testing

A Strength-Based Intervention to Improve Job Interview Skills in Neurodiverse Young Adults

Who this might be right for
ADHDDyslexiaLearning Disabilities
Kessler Foundation 50
Post-approval studies (Phase 4)Study completedNCT06185985
What this trial is testing

Open-label Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms

Who this might be right for
Attention-Deficit/Hyperactivity Disorder
Supernus Pharmaceuticals, Inc. 161
Large-scale testing (Phase 3)Study completedNCT01338818
What this trial is testing

Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder

Who this might be right for
Attention Deficit/Hyperactivity Disorder
Novartis Pharmaceuticals 299
Not applicableUnknownNCT03494478
What this trial is testing

Emotional Dysregulation in Adult ADHD.

Who this might be right for
Adult ADHD
University Hospital, Strasbourg, France 120
Testing effectiveness (Phase 2)Study completedNCT00640185
What this trial is testing

Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention-Deficit/Hyperactivity Disorder
AbbVie (prior sponsor, Abbott) 160
Testing effectiveness (Phase 2)Study completedNCT01174355
What this trial is testing

ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit and Hyperactivity Disorder
NeuroDerm Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00940693
What this trial is testing

Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD)

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Université de Montréal 40
Testing effectiveness (Phase 2)Study completedNCT00880217
What this trial is testing

Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Hyperactivity Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 430
Testing effectiveness (Phase 2)Study completedNCT00015223
What this trial is testing

Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5

Who this might be right for
Cocaine-Related DisordersSubstance-Related Disorders
National Institute on Drug Abuse (NIDA)
Large-scale testing (Phase 3)Study completedNCT03605680
What this trial is testing

A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

Who this might be right for
Attention Deficit DisorderAttention Deficit Hyperactivity Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 604
Large-scale testing (Phase 3)Study completedNCT00246220
What this trial is testing

The Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder.

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Janssen Pharmaceutica N.V., Belgium 402
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation